12:00 AM
 | 
Jul 29, 2013
 |  BC Week In Review  |  Financial News  |  Other Financial News

Mirati Therapeutics financial update

Mirati voluntarily delisted from the Toronto Stock Exchange. The company will continue trading on NASDAQ....

Read the full 53 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >